Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.clml.2023.12.008
PubMed Identifier: 38216397
Publication URI: http://europepmc.org/abstract/MED/38216397
Type: Journal Article/Review
Parent Publication: Clinical lymphoma, myeloma & leukemia
ISSN: 2152-2669